Lindsay A. Rosenwald M.D., Director at Checkpoint Therapeutics, Inc. (CKPT), bought 197,900 shares at $2.35 ($454K) on 2018-11-09, disclosed to the SEC on 2018-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.12 | 2,100 | $4K | 1.0% |
| 2 | $2.24 | 48,234 | $108K | 23.8% |
| 3 | $2.24 | 48,234 | $108K | 23.8% |
| 4 | $2.35 | 49,666 | $117K | 25.7% |
| 5 | $2.35 | 49,666 | $117K | 25.7% |
| Total | $2.29 avg | 197,900 |
| $454K |
| 100% |
| Filing → |
| FBIO | BUY | 2024-05-20 | $18K | — | Filing → |
| DERM | BUY | 2024-03-27 | $30K | — | Filing → |
| DERM | BUY | 2024-03-25 | $68K | — | Filing → |